United States Biotechnology & Medical Research

Briacell Therapeutics Corp (BCT)

Track

Track

Ticker: BCT Exchange: TOR
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Briacell Therapeutics Corp. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
2.8
Lustig, Marc 10% Security Holder of Issuer, Director of Issuer Non-Executive Director Large shareholder
Transaction date
Purchase
Price
201.97
Quantity 54,138 +16.3%
Value CA$4,349,778
0.5
Lustig Marc Non-Executive Director Large shareholder
Transaction date
Purchase
Price
284.24
Quantity 95,599 -11.1%
Value US$4,760,153
Bondarenko, Jamieson Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
82.61
Quantity 92,604 +44.1%
Value US$3,585,606
3.6
Bondarenko Jamieson Chairman Executive Director
Transaction date
Purchase
Price
4.58
Quantity 28,000 +19.7%
Value US$128,240
Bondarenko, Jamieson Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
5.35
Quantity 22,000 +18.4%
Value US$117,713
3.6
Bondarenko Jamieson Non-Executive Director
Transaction date
Purchase
Price
5.35
Quantity 22,000 +18.4%
Value US$117,700
2.8
Lustig, Marc 10% Security Holder of Issuer, Director of Issuer Non-Executive Director Large shareholder
Transaction date
Purchase
Price
7.70
Quantity 3,887 +0.2%
Value CA$29,945
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2025-11-26 2024-11-28 B Purchase
2.8
Lustig, Marc

10% Security Holder of Issuer, Director of Issuer

Non-Executive Director Large shareholder
54,138 +16.3%
201.97
CA$4,349,778 		54,138 +16.3% 201.97 CA$4,349,778
2024-05-20 2024-05-14 B Purchase
0.5
Lustig Marc
Non-Executive Director Large shareholder
95,599 -11.1%
284.24
US$4,760,153 		95,599 -11.1% 284.24 US$4,760,153
2022-12-28 2022-12-28 B Purchase
Bondarenko, Jamieson

Director of Issuer

Non-Executive Director
92,604 +44.1%
82.61
US$3,585,606 		92,604 +44.1% 82.61 US$3,585,606
2022-12-28 2022-12-28 B Purchase
3.6
Bondarenko Jamieson

Chairman

Executive Director
28,000 +19.7%
4.58
US$128,240 		28,000 +19.7% 4.58 US$128,240
2022-12-20 2022-12-20 B Purchase
Bondarenko, Jamieson

Director of Issuer

Non-Executive Director
22,000 +18.4%
5.35
US$117,713 		22,000 +18.4% 5.35 US$117,713
2022-12-20 2022-12-20 B Purchase
3.6
Bondarenko Jamieson
Non-Executive Director
22,000 +18.4%
5.35
US$117,700 		22,000 +18.4% 5.35 US$117,700
2025-11-26 2022-02-25 B Purchase
2.8
Lustig, Marc

10% Security Holder of Issuer, Director of Issuer

Non-Executive Director Large shareholder
3,887 +0.2%
7.70
CA$29,945 		3,887 +0.2% 7.70 CA$29,945
Explore more

More insider trading research around Briacell Therapeutics Corp

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America